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Moving bed biofilm reactors (MBBRs), as alternative to conventional activated sludge systems (CAS), are 
based on biofilm growing on specifically designed floating plastic carriers. Through prolonged physical 
retention of biomass as compared to CAS, MBBRs are particularly advantageous in the enrichment of slow 
growing bacteria within the microbial community. Recently, moving bed biofilm reactors (MBBRs) have 
been observed to improve the removal of a number of organic micropollutants under aerobic conditions. 
However, no study previously attempted to comprehensively elucidate micropollutant removal capabilities 
of MBBRs at different stages of biological wastewater treatment. In this study, we investigated the 
potential of MBBRs for the removal of micropollutants (n=22), mainly pharmaceuticals, in three 
laboratory-scale configurations: pre-denitrification (MBBR1), nitrification (MBBR2) and post-
denitrification (MBBR3). Figure 1 summarizes the pseudo-first-order biotransformation rate constants (kbio) 
obtained for the beta-blocker atenolol. The three MBBR systems presented improved kbio as compared to 
CAS for atenolol and for a number of pharmaceuticals (e.g., sulfamethoxazole, erythromycin). The post-
denitrifying MBBR3, which was supplemented with more readily degradable carbon sources (ethanol, 
methanol) compared to MBBR1, exhibited the highest kbio (Fig. 1). The availability of primary substrates 
(carbon and nitrogen) was found crucial for the biotransformation of pharmaceuticals in the three MBBR 
systems, suggesting removal via cometabolism. Typically recalcitrant substances (e.g., diclofenac) were 
only removed under nitrifying conditions, with kbio values comparably higher than CAS. Overall, our 
results suggest that MBBR can be a valuable alternative to CAS in enhancing the removal of 
micropollutants both under aerobic and anoxic conditions. 
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Figure 1 Comparison of biotransformation rate constants (kbio) for atenolol in MBBR1–3 with literature values from conventional 
activated sludge systems (CAS). 
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